ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marco Zenati
Robert J. Keenan
Rodney J. Landreneau
Bartley P. Griffith
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zenati, M.
Right arrow Articles by Griffith, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zenati, M.
Right arrow Articles by Griffith, B. P.

Ann Thorac Surg 1996;62:994-999
© 1996 The Society of Thoracic Surgeons


Original Articles: General Thoracic

Role of Lung Reduction in Lung Transplant Candidates With Pulmonary Emphysema

Marco Zenati, MD, Robert J. Keenan, MD, Frank C. Sciurba, MD, Jan D. Manzetti, PhD, Rodney J. Landreneau, MD, Bartley P. Griffith, MD

Divisions of Cardiothoracic Surgery and Pulmonary Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Background. The average waiting time for candidates for lung transplantation (LTx) with end-stage emphysema is 21 months with a 15% mortality. We hypothesized that lung reduction might offer an alternative to LTx.

Methods. Of 95 patients with end-stage emphysema evaluated by our LTx program, 45 were accepted for both lung reduction and LTx and 35 underwent lung reduction.

Results. All 35 patients survived lung reduction. Thirty patients had a follow-up of 3 months. There was a significant improvement (p < 0.05) of forced expiratory volume in 1 second (0.64 to 0.97 L), forced vital capacity (2.12 to 2.76 L), residual volume (5.62 to 4.26 L), maximum voluntary ventilation (28.1 to 38.5 L/min), 6-minute walk (904 to 1,012 feet), Borg dyspnea index (3.7 to 2.4), and arterial carbon dioxide tension (44.9 to 41.6 mm Hg). Twenty patients (66%) were removed from the LTx list due to their significant improvement (group A). Compared with the remaining 10 patients with 3 months of follow-up (group B), percent increase in forced expiratory volume in 1 second (70% in group A versus 27% in group B) and in forced vital capacity (41% group A versus 18% group B) and percent decrease in residual volume (26% group A versus 1.5% group B) were significantly better in group A (p < 0.01). Seven patients in group B were bridged to LTx; 6 of these patients (86%) had hypercarbia before lung reduction compared with 8 (40%) in group A (p < 0.05). All are alive after LTx: the forced expiratory volume in 1 second is 53% and the forced vital capacity is 64% of predicted.

Conclusions. Lung reduction is safe and effective in selected LTx candidates with end-stage emphysema and has the potential to provide an alternative to LTx. Long-term follow-up is warranted to confirm these results.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
O. Senbaklavaci, W. Wisser, C. Ozpeker, G. Marta, P. Jaksch, E. Wolner, and W. Klepetko
Successful lung volume reduction surgery brings patients into better condition for later lung transplantation
Eur. J. Cardiothorac. Surg., September 1, 2002; 22(3): 363 - 367.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. E.A. Burns, R. J. Keenan, W. F. Grgurich, J. D. Manzetti, and M. A. Zenati
Outcomes of lung volume reduction surgery followed by lung transplantation: a matched cohort study
Ann. Thorac. Surg., May 1, 2002; 73(5): 1587 - 1593.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J. Young, A. Fry-Smith, and C. Hyde
Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema
Thorax, September 1, 1999; 54(9): 779 - 789.
[Abstract] [Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Zenati, R. J. Keenan, A. P. Courcoulas, and B. P. Griffith
Lung volume reduction or lung transplantation for end-stage pulmonary emphysema?
Eur. J. Cardiothorac. Surg., July 1, 1999; 14(1): 27 - 32.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. T. FERGUSON, E. FERNANDEZ, M. R. ZAMORA, M. POMERANTZ, J. BUCHHOLZ, and B. J. MAKE
Improved Exercise Performance Following Lung Volume Reduction Surgery for Emphysema
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1195 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Wisser, E. Tschernko, O. Senbaklavaci, M. Kontrus, T. Wanke, E. Wolner, and W. Klepetko
Functional Improvement After Volume Reduction: Sternotomy Versus Videoendoscopic Approach
Ann. Thorac. Surg., March 1, 1997; 63(3): 822 - 827.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.